ABOUT EVENT

With the increased threats of antimicrobial resistance, demonstrating clinical confidence will be crucial to bacteriophage therapeutics in 2024. This community has reached an inflection point in 2023 with candidates entering clinic, maturing technologies of bioinformatics and phage engineering platform to improve specificity of bacteriophage for targeted therapeutics beyond AMR.

The 6th Bacteriophage Therapy Summit was your unique opportunity to be a part of the dialogue, meet phage leaders, large pharma, and venture capitalists from the likes of Merck, Pfizer, SNIPR Biome, Locus Biosciences, CARB-X, and AMR Action Fund to gain practical takeaways, and demonstrate the clinical utility of your bacteriophage to form meaningful partnerships.

Attendees had the opportunity to discuss renewed interests with Chief Executive Officers, Vice Presidents, Directors, and Senior Scientists of Bacteriophage, Microbiome Therapeutics, Infectious Diseases and AMR focusing on:

Icon 1

Evaluate the future of natural, engineered, hybrid, and synthetic phage

Icon 2

Understand the application of bioinformatics to improve sequencing and data processing for phage therapy

Icon 3

Navigate the challenges of clinical translatability from animal to human R&D models 

WHAT YOU MISSED:

Graphic 1
Graphic 2
Graphic 3
Graphic 4
Graphic 5

LEARN

how to design an ideal clinical trial through a collaborative workshop spearheaded by Phiogen

DISCOVER

how to apply AI in practice for development and production of phage from Tolka AI Therapeutics

BROADEN

your understanding of CRISPR in phage therapy with the newest results from SNIPR Biome

OPTIMIZE

your process development into good manufacturing practice with platform technologies from Merck

TAKE AWAY

key lessons on the scale up process for the agricultural industry with respect to pharmaceuticals from PhageLab

LEARN

how to design an ideal clinical trial through a collaborative workshop spearheaded by Phiogen

DISCOVER

how to apply AI in practice for development and production of phage from Tolka AI Therapeutics

BROADEN

your understanding of CRISPR in phage therapy with the newest results from SNIPR Biome

OPTIMIZE

your process development into good manufacturing practice with platform technologies from Merck

TAKE AWAY

key lessons on the scale up process for the agricultural industry with respect to pharmaceuticals from PhageLab

For the first time, I had a great experience in attending a conference with notable networking and contacts with the industry” - Physiogenex

WHO DID YOU MISS?

Who will you meet